Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.

Evans D, Miner T, Iannitti D, Akerman P, Cruff D, Maia-Acuna C, Harrington D, Habr F, Chauhan B, Berkenblit A, Stuart K, Sears D, Kennedy T, Safran H. Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study. Cancer Invest. 2007 Sep; 25(6):445-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.